Gargett Caroline E
Centre for Women's Health Research, Monash Institute of Medical Research, and Monash University Department of Obstetrics and Gynaecology, Monash Medical Centre, Clayton, Victoria, Australia.
Reprod Sci. 2007 Jul;14(5):405-24. doi: 10.1177/1933719107306231.
The derivation of human embryonic stem (hES) cells heralds a new era in stem cell research, generating excitement for their therapeutic potential in regenerative medicine. Pioneering work of embryologists, developmental biologists, and reproductive medicine practitioners in in vitro fertilization clinics has facilitated hES cell research. This review summarizes current research focused on optimizing hES cell culture conditions for good manufacturing practice, directing hES cell differentiation toward trophectoderm and germ cells, and approaches used to reprogram cells for pluripotent cell derivation. The identification of germ stem cells in the testis and the recent controversy over their existence in the ovary raise the possibility of harnessing them for treating young cancer survivors. There is also the potential to harvest fetal stem cells with pluripotent cell-like properties from discarded placental tissues. The recent identification of adult stem/progenitor cell activity in the human endometrium offers a new understanding of common gynecological diseases. Discoveries resulting from research into embryonic, germ, fetal, and adult stem cells are highly relevant to human reproduction.
人类胚胎干细胞(hES细胞)的衍生开启了干细胞研究的新纪元,其在再生医学中的治疗潜力令人兴奋不已。胚胎学家、发育生物学家以及体外受精诊所的生殖医学从业者的开创性工作推动了hES细胞研究。本综述总结了当前的研究,这些研究聚焦于优化hES细胞培养条件以符合药品生产质量管理规范,引导hES细胞向滋养外胚层和生殖细胞分化,以及用于重编程细胞以获得多能细胞衍生的方法。睾丸中生殖干细胞的鉴定以及近期关于其在卵巢中是否存在的争议,增加了利用它们治疗年轻癌症幸存者的可能性。从废弃胎盘组织中获取具有多能细胞样特性的胎儿干细胞也具有潜力。近期在人类子宫内膜中发现的成体干细胞/祖细胞活性为常见妇科疾病提供了新的认识。对胚胎、生殖、胎儿和成体干细胞的研究发现与人类生殖高度相关。